Who gets sick? Much of COVID-19’s prevalence, severity, and lethality may have to do with viral particles you are exposed to—the issue of viral load, also called viral dose. Not much is written on ...

Most women living with HIV achieved an immunologic response after 2 years of initiating antiretroviral therapy. A higher baseline HIV viral load increased the odds of an immunologic response in women ...

New research reveals how lingering viral activity and immune disruption contribute to long COVID, highlighting novel therapeutic strategies that could change the course of treatment for millions.

An international research team has discovered a critical protein that acts as a 'switch' regulating immune responses to viruses. Even after the COVID-19 pandemic, various new infectious diseases ...

The Bioxyytran Trial reports complete elimination of viral load in 100% of patients at day 7 versus placebo (p=.001). Boston, Massachusetts, ...

The decrease in CD4 cells during HIV infection seems to be driven by immune activation, which does not always correlate with viral load. Experienced clinicians are all too familiar with the ...

Living with HIV means becoming fluent in a language of numbers that might seem confusing at first but actually hold the key to your health and future. Two numbers in particular – your viral load and ...

Because many different types of cancer cells overexpress programmed death-ligand 1 (PD-L1), this cell surface protein is a ...